2016
DOI: 10.1186/s41016-015-0019-y
|View full text |Cite
|
Sign up to set email alerts
|

Granulomatous hypophysitis: experience with eight surgical cases of a single center

Abstract: Background: Although primary hypophysitis is not uncommon, a granulomatous etiology of hypophysitis is relatively rare. Radiological and diagnostic characteristics of several isolated cases have been described to date. However, to the best of our knowledge, surgical treatment of eight cases of granulomatous hypophysitis confirmed by histopathology has not yet been reported. Methods: A retrospective study was performed to review cases of granulomatous hypophysitis from November 2003 to November 2013 in our neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 17 publications
1
10
0
Order By: Relevance
“…It is believed to be either idiopathic or associated with other autoimmune disorders. Hypophysitis can be categorized histopathologically as LH, GH, xanthomatous hypophysitis, and plasmocytic hypophysitis, also known as IgG4-related hypophysitis (2,3). Mixed histology can be seen, however.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…It is believed to be either idiopathic or associated with other autoimmune disorders. Hypophysitis can be categorized histopathologically as LH, GH, xanthomatous hypophysitis, and plasmocytic hypophysitis, also known as IgG4-related hypophysitis (2,3). Mixed histology can be seen, however.…”
Section: Discussionmentioning
confidence: 99%
“…It causes pituitary enlargement that mimics a macroadenoma (6). Secondary GH can be due to an infection, systemic inflammatory disorders such as sarcoidosis, Wegener granulomatosis, Crohn disease, Takayasu arteritis, Cogan syndrome, or a side effect of some medications, mostly in those receiving immunotherapy for metastatic melanoma with anti-CTLA4 and anti-PDi antibodies (3,5,8). Our patient's rheumatology evaluations, including DNA antibody, SSA/SSB antibodies, anti-Smith/RNP antibody, JO-1 antibody, anti-nuclear antibody, and rheumatoid factor, were within normal limits.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations